• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Btk 是 TREM-1/DAP12 信号通路中的正向调节剂。

Btk is a positive regulator in the TREM-1/DAP12 signaling pathway.

机构信息

German Cancer Research Center (DKFZ), Innate Immunity, Heidelberg, Germany.

出版信息

Blood. 2011 Jul 28;118(4):936-45. doi: 10.1182/blood-2010-11-317016. Epub 2011 Jun 9.

DOI:10.1182/blood-2010-11-317016
PMID:21659545
Abstract

The triggering receptor expressed on myeloid cells 1 (TREM-1) has been implicated in the production of proinflammatory cytokines and chemokines during bacterial infection and sepsis. For downstream signal transduction, TREM-1 is coupled to the ITAM-containing adaptor DAP12. Here, we demonstrate that Bruton tyrosine kinase (Btk), a member of the Tec kinases, becomes phosphorylated upon TREM-1 triggering. In U937-derived cell lines, in which expression of Btk was diminished by shRNA-mediated knockdown, phosphorylation of Erk1/2 and PLCγ1 and Ca²⁺ mobilization were reduced after TREM-1 stimulation. Importantly, TREM-1-induced production of the pro-inflammatory cytokines, TNF-α and IL-8, and up-regulation of activation/differentiation cell surface markers were impaired in Btk knockdown cells. Similar results were obtained upon TREM-1 stimulation of BMDCs of Btk(-/-) mice. The analysis of cells containing Btk mutants revealed that intact membrane localization and a functional kinase domain were required for TREM-1-mediated signaling. Finally, after TREM-1 engagement, TNF-α production by PBMCs was reduced in the majority of patients suffering from X-linked agammaglobulinemia (XLA), a rare hereditary disease caused by mutations in the BTK gene. In conclusion, our data identify Btk as a positive regulator in the ITAM-mediated TREM-1/DAP12 pathway and suggest its implication in inflammatory processes.

摘要

髓样细胞表达的触发受体 1(TREM-1)已被牵涉到细菌感染和脓毒症期间促炎细胞因子和趋化因子的产生。对于下游信号转导,TREM-1 与含有 ITAM 的衔接蛋白 DAP12 偶联。在这里,我们证明 Bruton 酪氨酸激酶(Btk),一种 Tec 激酶家族的成员,在 TREM-1 触发后发生磷酸化。在 U937 衍生的细胞系中,通过 shRNA 介导的敲低降低了 Btk 的表达,在 TREM-1 刺激后,Erk1/2 和 PLCγ1 的磷酸化以及 Ca²⁺动员减少。重要的是,在 Btk 敲低细胞中,TREM-1 诱导的促炎细胞因子 TNF-α 和 IL-8 的产生以及激活/分化细胞表面标志物的上调受损。在 Btk(-/-)小鼠的 BMDC 中进行 TREM-1 刺激时也获得了相似的结果。对含有 Btk 突变体的细胞的分析表明,完整的膜定位和功能激酶结构域是 TREM-1 介导的信号所必需的。最后,在 TREM-1 结合后,大多数患有 X 连锁无丙种球蛋白血症(XLA)的患者的 PBMCs 中 TNF-α 的产生减少,XLA 是一种由 BTK 基因突变引起的罕见遗传性疾病。总之,我们的数据将 Btk 鉴定为 ITAM 介导的 TREM-1/DAP12 途径中的正调节剂,并提示其在炎症过程中的作用。

相似文献

1
Btk is a positive regulator in the TREM-1/DAP12 signaling pathway.Btk 是 TREM-1/DAP12 信号通路中的正向调节剂。
Blood. 2011 Jul 28;118(4):936-45. doi: 10.1182/blood-2010-11-317016. Epub 2011 Jun 9.
2
Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells.非T细胞激活连接蛋白(NTAL)负向调节髓样细胞中TREM-1/DAP12诱导的炎性细胞因子产生。
J Immunol. 2007 Feb 15;178(4):1991-9. doi: 10.4049/jimmunol.178.4.1991.
3
The TREM-1/DAP12 pathway.触发受体表达于髓系细胞-1/DNAX 激活蛋白 12 通路
Immunol Lett. 2008 Mar 15;116(2):111-6. doi: 10.1016/j.imlet.2007.11.021. Epub 2007 Dec 26.
4
Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines.X 连锁无丙种球蛋白血症患者中 Toll 样受体 4、7 和 8 激活的髓样细胞产生增强的炎症细胞因子。
J Allergy Clin Immunol. 2012 Jan;129(1):184-90.e1-4. doi: 10.1016/j.jaci.2011.10.009. Epub 2011 Nov 16.
5
TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells.触发受体表达于髓系细胞2(TREM-2)介导的信号传导可诱导成熟髓样树突状细胞摄取并保留抗原。
J Immunol. 2008 Dec 1;181(11):7863-72. doi: 10.4049/jimmunol.181.11.7863.
6
TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells.TREM-2,髓系细胞触发受体-2,负向调节树突状细胞中的 TLR 反应。
Eur J Immunol. 2012 Jan;42(1):176-85. doi: 10.1002/eji.201141679. Epub 2011 Dec 12.
7
Involvement of the TREM-1/DAP12 pathway in the innate immune responses to Porphyromonas gingivalis.TREM-1/DAP12 途径在牙龈卟啉单胞菌固有免疫反应中的作用。
Mol Immunol. 2011 Oct;49(1-2):387-94. doi: 10.1016/j.molimm.2011.09.012. Epub 2011 Oct 2.
8
The linker for activation of B cells (LAB)/non-T cell activation linker (NTAL) regulates triggering receptor expressed on myeloid cells (TREM)-2 signaling and macrophage inflammatory responses independently of the linker for activation of T cells.B 细胞激活连接蛋白(LAB)/非 T 细胞激活连接蛋白(NTAL)可调节髓系细胞表达的触发受体(TREM)-2 信号转导和巨噬细胞炎症反应,而与 T 细胞激活连接蛋白无关。
J Biol Chem. 2010 Jan 29;285(5):2976-85. doi: 10.1074/jbc.M109.038398. Epub 2009 Nov 30.
9
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.人 NACHT、LRR 和 PYD 结构域包含蛋白 3(NLRP3)炎症小体的活性受布鲁顿酪氨酸激酶调节,并且可能成为其作用靶点。
J Allergy Clin Immunol. 2017 Oct;140(4):1054-1067.e10. doi: 10.1016/j.jaci.2017.01.017. Epub 2017 Feb 16.
10
Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases.髓系细胞表达的触发受体家族信号在炎症性疾病中的新兴作用。
Expert Rev Clin Immunol. 2014 Feb;10(2):243-56. doi: 10.1586/1744666X.2014.866519. Epub 2013 Dec 10.

引用本文的文献

1
Identification and Exploration of Pyroptosis-Related Genes in Macrophage Cells Reveal Necrotizing Enterocolitis Heterogeneity Through Single-Cell and Bulk-Sequencing.巨噬细胞中焦亡相关基因的鉴定与探索通过单细胞和批量测序揭示坏死性小肠结肠炎的异质性
Int J Mol Sci. 2025 Apr 24;26(9):4036. doi: 10.3390/ijms26094036.
2
Inhibition of Bruton's tyrosine kinase restricts neuroinflammation following intracerebral hemorrhage.抑制布鲁顿酪氨酸激酶可限制脑出血后的神经炎症。
Theranostics. 2025 Jan 1;15(2):494-508. doi: 10.7150/thno.101024. eCollection 2025.
3
TREM2 aggravates sepsis by inhibiting fatty acid oxidation via the SHP1/BTK axis.
触发受体表达于髓细胞2(TREM2)通过小磷酸酶1(SHP1)/布鲁顿酪氨酸激酶(BTK)轴抑制脂肪酸氧化,从而加重脓毒症。
J Clin Invest. 2024 Oct 15;135(1):e159400. doi: 10.1172/JCI159400.
4
Integrated transcriptomic analysis and machine learning for characterizing diagnostic biomarkers and immune cell infiltration in fetal growth restriction.整合转录组分析和机器学习用于鉴定胎儿生长受限的诊断生物标志物和免疫细胞浸润。
Front Immunol. 2024 Sep 4;15:1381795. doi: 10.3389/fimmu.2024.1381795. eCollection 2024.
5
Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies.布鲁顿酪氨酸激酶(BTK)抑制剂依鲁替尼和阿卡替尼在B细胞恶性肿瘤以外的人类疾病中的临床试验。
Front Oncol. 2021 Oct 28;11:737943. doi: 10.3389/fonc.2021.737943. eCollection 2021.
6
Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTK/mTOR/VEGF Signaling.阿卡拉布替尼与雷帕霉素联合治疗通过下调BTK/mTOR/VEGF信号通路抑制胶质瘤干细胞并促进血管正常化。
Pharmaceuticals (Basel). 2021 Aug 29;14(9):876. doi: 10.3390/ph14090876.
7
Bruton's Tyrosine Kinase-Mediated Signaling in Myeloid Cells Is Required for Protective Innate Immunity During Pneumococcal Pneumonia.布鲁顿酪氨酸激酶介导的髓系细胞信号传导在肺炎球菌肺炎期间的保护性固有免疫中是必需的。
Front Immunol. 2021 Sep 6;12:723967. doi: 10.3389/fimmu.2021.723967. eCollection 2021.
8
Multifaceted Immunomodulatory Effects of the BTK Inhibitors Ibrutinib and Acalabrutinib on Different Immune Cell Subsets - Beyond B Lymphocytes.布鲁顿酪氨酸激酶(BTK)抑制剂依鲁替尼和阿卡拉布替尼对不同免疫细胞亚群的多方面免疫调节作用——超越B淋巴细胞。
Front Cell Dev Biol. 2021 Aug 13;9:727531. doi: 10.3389/fcell.2021.727531. eCollection 2021.
9
BTK inhibitors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A systematic review.用于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的布鲁顿酪氨酸激酶(BTK)抑制剂:一项系统评价
Clin Immunol. 2021 Sep;230:108816. doi: 10.1016/j.clim.2021.108816. Epub 2021 Aug 2.
10
Accuracy of triggering receptor expressed on myeloid cells 1 in diagnosis and prognosis of acute myocardial infarction: a prospective cohort study.髓系细胞表达的触发受体1在急性心肌梗死诊断和预后中的准确性:一项前瞻性队列研究。
PeerJ. 2021 Jun 22;9:e11655. doi: 10.7717/peerj.11655. eCollection 2021.